These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6369285)

  • 41. [Treatment with antiplatelet drugs. Current status of knowledge].
    Dettori AG; Pini M; Quintavalla R
    Recenti Prog Med; 1979 Sep; 67(3):346-67. PubMed ID: 392656
    [No Abstract]   [Full Text] [Related]  

  • 42. Platelet aggregation and atherosclerosis.
    Valladares BK; Lemberg L
    Heart Lung; 1986 Mar; 15(2):211-4. PubMed ID: 3633253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [PRoFESS study presented. Change in secondary prevention].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():96-7. PubMed ID: 14579494
    [No Abstract]   [Full Text] [Related]  

  • 44. [Thrombosis prevention with thrombocyte aggregation inhibitors in the venous system].
    Schöndorf TH
    Med Welt; 1982 Jun; 33(23):851-4. PubMed ID: 7050615
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment and prevention of thromboembolism with anti-aggregation drugs].
    Donner L
    Vnitr Lek; 1981 May; 27(5):487-95. PubMed ID: 7245635
    [No Abstract]   [Full Text] [Related]  

  • 46. Plasma thromboglobulin and platelet aggregation index in transient ischaemic attack: effect of aspirin and dipyridamole therapy.
    Aushri Z; Berginer V; Nathan I; Dvilansky A
    Int J Clin Pharmacol Res; 1983; 3(5):339-42. PubMed ID: 6206005
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)].
    Bousser MG; Eschwege E; Haguenau M; Lefauconnier JM; Touboul D; Touboul PJ
    Rev Neurol (Paris); 1981; 137(5):333-41. PubMed ID: 7027408
    [No Abstract]   [Full Text] [Related]  

  • 48. Aspirin--effective in males threatened with stroke.
    Barnett HJ; McDonald JW; Sackett DL
    Stroke; 1978; 9(4):295-8. PubMed ID: 675741
    [No Abstract]   [Full Text] [Related]  

  • 49. [Anti-aggregation therapy of patients with ischemic heart disease].
    Liusov VA; Savenkov MP
    Ter Arkh; 1988; 60(8):55-9. PubMed ID: 3227479
    [No Abstract]   [Full Text] [Related]  

  • 50. [Platelet antiaggregants: review of the literature (author's transl)].
    Sternon J
    Rev Med Brux; 1981 May; 2(5):487-92. PubMed ID: 7020033
    [No Abstract]   [Full Text] [Related]  

  • 51. [Antithrombotic therapy in ischemic stroke and transient ischemic attack].
    Overgaard K; Poulsen TS; Husted SE
    Ugeskr Laeger; 2007 Oct; 169(40):3379-82. PubMed ID: 17953858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 53. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
    Gebel JM
    J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
    Genton E; Gent M; Hirsh J; Harker LA
    N Engl J Med; 1975 Dec; 293(25):1296-300. PubMed ID: 1102986
    [No Abstract]   [Full Text] [Related]  

  • 56. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
    Friedman LM
    Circulation; 1980 Dec; 62(6 Pt 2):V88-9. PubMed ID: 7002355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Platelet anti-aggregant drugs and ischemic cardiopathy: evaluation of the effect on platelet aggregation and on antithrombin III].
    Avellone G; Mandalà V; Novo S; Pinto A; Riolo FP; Davì G; Raneli G
    Boll Soc Ital Cardiol; 1981; 26(8):697-712. PubMed ID: 6289854
    [No Abstract]   [Full Text] [Related]  

  • 58. Use of platelet antagonists in the treatment of migraine.
    Dalessio DJ
    Headache; 1976 Jul; 16(3):129-30. PubMed ID: 965226
    [No Abstract]   [Full Text] [Related]  

  • 59. Antiplatelet therapy.
    Sloan RW
    Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiplatelet drugs in thromboembolism.
    Hirsh J
    Postgrad Med; 1979 Sep; 66(3):119-23, 126-7. PubMed ID: 382146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.